G418-mediated ribosomal read-through of a nonsense mutation causing autosomal recessive proximal renal tubular acidosis

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 3, 2008, Pages

  Azimov, Rustam ^a   Abuladze, Natalia ^a   Sassani, Pakan ^a   Newman, Debra ^a   Kao, Liyo ^a   Liu, Weixin ^a   Orozco, Nicholas ^a   Ruchala, Piotr ^a   Pushkin, Alexander ^a   Kurtz, Ira ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aminoglycoside; Geneticin; Q29X; Ribosome

Indexed keywords

ANTIBIOTIC G 418; BICARBONATE; COTRANSPORTER; SODIUM ION; ANTIAMEBIC AGENT; BICARBONATE SODIUM COTRANSPORTER; GENTAMICIN; MESSENGER RNA; SLC4A4 PROTEIN, HUMAN;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; AUTOSOMAL RECESSIVE PROXIMAL RENAL TUBULAR ACIDOSIS; CELL MEMBRANE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ACIDOSIS; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SODIUM TRANSPORT; STOP CODON; WILD TYPE; CELL LINE; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM;

ACIDOSIS, RENAL TUBULAR; AMEBICIDES; CELL LINE; CODON, NONSENSE; GENE EXPRESSION; GENTAMICINS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; RNA, MESSENGER; SODIUM-BICARBONATE SYMPORTERS;

EID: 54449096913     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00015.2008     Document Type: Article

References (68)

1. Abuladze N, Song M, Pushkin A, Newman D, Lee I, Nicholas S, Kurtz I. Structural organization of the human NBC1 gene: kNBC1 is transcribed from an alternative promoter in intron 3. Gene 251: 109-122, 2000.
2. Atkinson J, Martin R. Mutations to nonsense codons in human genetic disease: implications for gene therapy by nonsense suppressor tRNAs. Nucleic Acids Res 22: 1327-1334, 1994.
3. Barton-Davis ER, Cordier L, Shoturma DI, Leland SE, Sweeney HL. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 104: 375-381, 1999.
4. Beauchamp D, Laurent G, Grenier L, Gourde P, Zanen J, Heuson-Stiennon JA, Bergeron MG. Attenuation of gentamicin-induced nephrotoxicity in rats by fleroxacin. Antimicrob Agents Chemother 41:1237-1245, 1997.
5. Bedwell DM, Kaenjak A, Benos DJ, Bebok Z, Bubien JK, Hong J, Tousson A, Clancy JP, Sorscher EJ. Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line. Nat Med 3: 1280-1284, 1997.
6. Bethune C, Bui T, Liu ML, Kay MA, Ho RJY. Development of a high-performance liquid chromatographic assay for G418 sulfate (geneticin). Antimicro Agents Chem 41: 661-664, 1997.
7. Bidou L, Hatin I, Perez N, Allamand V, Panthier JJ, Rousset JP. Premature stop codons involved in muscular dystrophies show a broad spectrum of read through efficiencies in response to gentamicin treatment. Gene Ther 11: 619-627, 2004.
8. Bok D, Schibler MJ, Pushkin A, Sassani P, Abuladze N, Naser Z, Kurtz I. Immunolocalization of electrogenic sodium-bicarbonate cotransporters pNBC1 and kNBC1 in the rat eye. Am J Physiol Renal Physiol 281: F920-F935, 2001.
9. Burke JF, Mogg AE. Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin. Nucleic Acids Res 13: 6265-6272, 1985.
10. Chernikov VG, Terekhov SM, Krokhina TB, Shishkin SS, Smirnova TD, Kalashnikova EA, Adnoral NV, Rebrov LB, Denisov-Nikol'skii YI, Bykov VA. Comparison of cytotoxicity of aminoglycoside antibiotics using a panel cellular biotest system. Bull Exp Biol Med 135: 103-105, 2003.
11. Dinour D, Chang MH, Satoh J, Smith BL, Angle N, Knecht A, Serban I, Holtzman EJ, Romero MF. A novel missense mutation in the sodium bicarbonate cotransporter (NBCe1/SLC4A4) causes proximal tubular acidosis and glaucoma through ion transport defects. J Biol Chem 279: 52238-52246, 2004.
12. Dunant P, Walter MC, Karpati G, Lochmuller H. Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle. Muscle Nerve 27: 624-627, 2003.
13. Gilbert DN, Wood CA, Kohlhepp SJ, Kohnen PW, Houghton DC, Finkbeiner HC, Lindsley J, Bennett WM. Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis 159: 945-953, 1989.
14. Grayson C, Chapple JP, Willison KR, Webster AR, Hardcastle AJ, Cheetham ME. In vitro analysis of aminoglycoside therapy for the Arg120 stop nonsense mutation in RP2 patients. J Med Genet 39: 62-67, 2002.
15. Graziano C, D'Elia AV, Mazzanti L, Moscano F, Guidelli Guidi S, Scarano E, Turchetti D, Franzoni E, Romeo G, Damante G, Seri M. A de novo nonsense mutation of PAX6 gene in a patient with aniridia, ataxia, and mental retardation. Am J Med Gen 143: 1802-1805, 2007.
16. Guillonneau X, Piriev NI, Danciger M, Kozak CA, Cideciyan AV, Jacobson SG, Farber DB. A nonsense mutation in a novel gene is associated with retinitis pigmentosa in a family linked to the RPI locus. Hum Mol Gen 8: 1541-1546, 1999.
17. Hatsukawa Y, Nakao T, Yamagishi T, Okamoto N, Isashiki Y. Novel nonsense mutation (Tyr44stop) of the Norrie disease gene in a Japanese family. Brit J Ophthamol 86:1452-1453, 2002.
18. Helip-Wooley A, Park MA, Lemons RM, Thoene JG. Expression of CTNS alleles: subcellular localization and aminoglycoside correction in vitro. Mol Genet Metab 75: 128-133, 2002.
19. Hermann T, Tereshko V, Skripkin E, Patel DJ. Apramycin recognition by the human ribosomal decoding site. Blood Cells Mol Dis 38: 193-198, 2007.
20. Horita S, Yamada H, Inatomi J, Moriyama N, Sekine T, Igarashi T, Endo Y, Dasouki M, Ekim M, Al-Gazali L, Shimadzu M, Seki G, Fujita T. Functional analysis of NBC1 mutants associated with proximal renal tubular acidosis and ocular abnormalities. J Am Soc Nephrol 16: 2270-2278, 2005.
21. Horita S, Yamada H, Inatomi Takashi J, S, Igarashi T, Seki G, Fujita T. Mechanism of NBC1 inactivation by mutations identified in patients with proximal renal tubular acidosis and ocular abnormalities (Abstract). J Am Soc Nephrol 16: 123A, 2005.
22. Howard M, Frizzell RA, Bedwell DM. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med 2: 467-469, 1996.
23. Howard MT, Shirts BH, Petros LM, Flanigan KM, Gesteland RF, Atkins JF. Sequence specificity of aminoglycoside-induced stop condon read-through: potential implications for treatment of Duchenne muscular dystrophy. Ann Neurol 48: 164-169, 2000.
24. Howard MT, Anderson CB, Fass U, Khatri S, Gesteland RF, Atkins JF, Flanigan KM. Read-through of dystrophin stop codon mutations induced by aminoglycosides. Ann Neurol 55: 422-426, 2004.
25. Igarashi T, Inatomi J, Sekine T, Cha SH, Kanai Y, Kunimi M, Tsukamoto K, Satoh H, Shimadzu M, Tozawa F, Mori T, Shiobara M, Seki G, Endou H. Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nat Genet 23: 264-266, 1999.
26. - cotransporter gene (SLC4A4) in a patient with permanent isolated proximal renal tubular acidosis and bilateral glaucoma. J Am Soc Nephrol 12: 713-718, 2001.
27. Inatomi J, Horita S, Braverman N, Sekine T, Yamada H, Suzuki Y, Kawahara K, Moriyama Kudo N, A, Kawakami H, Shimadzu M, Endou H, Fujita T, Seki G, Igarashi T. Mutational and functional analysis of SLC4A4 in a patient with proximal renal tubular acidosis. Pflügers Arch 448: 438-444, 2004.
28. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schröder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC. X-linked Alport syndrome natural history in 195 families and genotype-phenotype correlations in males J Am Soc Nephrol 11:649-657, 2000.
29. Karimi Pavlov R, MY, Buckingham RH, Ehrenberg M. Novel roles for classical factors at the interface between translation termination and initiation. Mol Cell 3: 601-609, 1999.
30. Kaul M, Barbieri CM, Pilch DS. Fluorescence-based approach for detecting and characterizing antibiotic-induced conformational changes in ribosomal RNA: comparing aminoglycoside binding to prokaryotic and eukaryotic ribosomal RNA sequences. J Am Chem Soc 126: 3447-3453, 2004.
31. Kawamoto K, Sha SH, Minoda R, Izumikawa M, Kuriyama H, Schacht J, Raphael Y. Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther 9: 173-181, 2004.
32. Keeling KM, Brooks DA, Hopwood JJ, Li P, Thompson JN, Bedwell DM. Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation. Hum Mol Genet 10: 291-299, 2001.
33. Keeling KM, Bedwell DM. Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system. J Mol Med 80: 367-376, 2002.
34. Koeberl DD, Bottema CDK, Sarkar G, Ketterling Chen SH RP, Sommer SS. Recurrent nonsense mutations at arginine residues cause severe hemophilia B in unrelated hemophiliacs. Hum Gen 84: 387-390, 1990.
35. Kondo J, François B, Urzhumtsev A, Westhof E. Crystal structure of the Homo sapiens cytoplasmic ribosomal decoding site complexed with apramycin. Angew Chem Int Ed Engl 45: 3310-3314, 2006.
36. Kondo J, Urzhumtsev A, Westhof E. Two conformational states in the crystal structure of the Homo sapiens cytoplasmic ribosomal decoding A site. Nucl Acids Res 34: 676-685, 2006.
37. Kondo J, Hainrichson M, Nudelman I, , Shallom-Shezifi D, Barbieri CM, Pilch DS, Westhof E, Baasov T. Differential selectivity of natural and synthetic aminoglycosides towards the eukaryotic and prokaryotic decoding A sites. Chembiochem 8:1700-1709, 2007.
38. +-ATPase regulate intracellular pH in the rabbit S3 proximal tubule. J Clin Invest 80: 928-935, 1987.
39. - cotransporter NBC1 show abnormal trafficking in polarized kidney cells: a basis of proximal renal tubular acidosis. Am J Physiol Renal Physiol 289: F61-F71, 2005.
40. Lynch SR, Gonzalez RL, Puglisi JD. Comparison of X-ray crystal structure of the 30S subunit-antibiotic complex with NMR structure of decoding site oligonucleotide-paromomycin complex. Structure 11: 43-53, 2003.
41. Manuvakhova M, Keeling K, Bedwell DM. Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. RNA 6: 1044-1055, 2000.
42. Martin R, Mogg AE, Heywood LA, Nitschke L, Burke JF. Aminoglycoside suppression at UAG, UAA and UGA codons in Escherichia coli and human tissue culture cells. Mol Gen Genet 217: 411-418, 1989.
43. Mingeot-Leclerq M, Tulkens PM. Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43: 1003-1012, 1999.
44. Nilsson M, Ryden-Aulin M. Glutamine is incorporated at the nonsense codons UAG and UAA in a suppressor-free Escherichia coli strain. Biochim Biophys Acta 1627: 1-6, 2003.
45. Nudelman I, Rebibo-Sabbah A, Shallom-Shezifi D, Hainrichson M, Stahl I, Ben-Yosef T, Baasov T. Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations. Bioorg Med Chem Lett 16: 6310-6315, 2006.
46. 2-) transporters: classification, function, structure, genetic diseases, and knockout models. Am J Physiol Renal Physiol 290: F580-F599, 2006.
47. Rebibo-Sabbah A, Nudelmanm I, Ahmed ZM, Baasov T, Ben-Yosef T. In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome. Hum Genet 122: 373-381, 2007.
48. Sangkuhl K, Schulz A, Rompler H, Yun J, Wess J, Schoneberg T. Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo. Hum Mol Genet 13: 893-903, 2004.
49. Sandoval RM, Reilly JP, Running W, Campos SB, Santos J, Phillips CL, Molitoris BA. A non-nephrotoxic gentamicin congener that retains antimicrobial efficacy. J Am Soc Nephrol 17: 2697-2705, 2006.
50. - cotransporter (NBC-1) variants in rat and human pancreas. Am J Physiol Cell Physiol 284: C729-C737, 2003.
51. Sener G, Sehirli AO, Altunbas HZ, Ersoy Y, Paskaloglu K, Arbak S, Ayanoglu-Dulger G. Melatonin protects against gentamicin-induced nephrotoxicity in rats. J Pineal Res 32: 231-236, 2002.
52. Simonelli F, Testa F, Zernant J, Nesti A, Settimio R, Rinaldi E, Aliikmets R. Association of a homozygous nonsense mutation in the ABCA4 (ABCR) gene with cone-rod dystrophy phenotype in an Italian family. Ophthal Res 36: 82-88, 2004.
53. Tatishchev Abuladze S, N, Pushkin A, Newman D, Weixin L, David W, Sachs G, Kurtz I. Identification of membrane topography of the electrogenic sodium bicarbonate cotransporter pNBC1 by in vitro transcription/translation. Biochemistry 42: 755-765, 2003.
54. Toye AM, Parker MD, Daly CM, Lu J, Virkki LV, Pelletier MF, Boron WF. The human NBCe1-A mutant R881C, associated with proximal renal tubular acidosis, retains function but is mistargeted in polarized renal epithelia. Am J Physiol Cell Physiol 291: C788-C801, 2006.
55. Thibault N, Grenier L, Simard M, Bergeron MG, Beauchamp. D. Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity. Antimicrob Agents Chemother 38: 1027-1035, 1994.
56. Thibault N, Grenier L, Simard M, Bergeron MG, Beauchamp D. Protection against gentamicin nephrotoxicity by daptomycin in nephrectomized rats. Life Sci 56: 1877-1887, 1995.
57. Usui T, Hara M, Satoh H, Moriyama N, Kagaya H, Amano S, Oshika T, Ishii Y, Ibaraki N, Hara C, Kunimi M, Noiri E, Tsukamoto K, Inatomi J, Kawakami H, Endou H, Igarashi T, Goto A, Fujita T, Araie M, Seki G. Molecular basis of ocular abnormalities associated with proximal renal tubular acidosis. J Clin Invest 108: 107-115, 2001.
58. Valleix S, Niel F, Nedelec B, Algros MP, Schwartz C, Delbosc B, Delpech M, Kantelip B. Homozygous nonsense mutation in the FOXE3 gene as a cause of congenital primary aphakia in humans. Am J Hum Genet 79: 358-364, 2006.
59. Vicens Q, Westhof E. Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide. J Mol Biol 326: 1175-1188, 2003.
60. Wagner KR, Hamed S, Hadley. DW, Gropman AL, Burstein AH, Escolar DM, Hoffman EP, Fischbeck KH. Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann Neurol 49: 706-711, 2001.
61. Watanabe A, Nagai J, Adachi Y, Katsube T, Kitahara Y, Murakami T, Takano M. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists. J Cont Rel 95: 423-433, 2003.
62. Welch E, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, Paushkin S, Patel M, Trotta CR, Hwang S, Wilde RG, Karp G, Takasugi J, Chen G, Jones S, Ren H, Moon YC, Corson D, Turpoff AA, Campbell JA, Conn MM, Khan A, Almstead NG, Hedrick J, Mollin A, Risher N, Weetall M, Yeh S, Branstrom AA, Colacino JM, Babiak J, Ju WD, Hirawat S, Northcutt VJ, Miller LL, Spatrick P, He F, Kawana M, Feng H, Jacobson A, Peltz SW, Sweeney HL. PTC124 targets genetic disorders caused by nonsense mutations. Nature 447: 87-91, 2007.
63. Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, Aviram M, Bdolah-Abram T, Bebok Z, Shushi L, Kerem B, Kerem E. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 349: 1433-1441, 2003.
64. Xi B, Guan F, Lawrence DS. Enhanced production of functional proteins from defective genes. J Am Chem Soc 126: 5660-5661, 2004.
65. Yoshida S, Honda M, Yoshida A, Nakao S, Got0, Y, Nakamura T, Fujisawa K, Ishibashi T. Novel mutation in ABCC6 gene in a Japanese pedigree with pseudoxanthoma elasticum and retinitis pigmentosa. Eye 19: 215-217, 2005.
66. Youssoufian H, Antonarakis SE, Bell W, Griffin AM, Kazazian HH Jr. Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides. Am J Hum Genet 42: 718-725, 1988.
67. Zhu Q, Lee DWK, Casey JR. Novel topology in C-terminal region of the human plasma membrane anion exchanger, AE1. J Biol Chem 278: 3112-3120, 2003.
68. Zingman LV, Park S, Olson TM, Alekseev AE, Terzic A. Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy. Clin Pharmacol Ther 81: 99-103, 2007.